Age of diagnosis of breast cancer in China: Almost 10 years earlier than in the United States and the European Union

Asian Pacific Journal of Cancer Prevention

Volumn 15, Issue 22, 2014, Pages 10021-10025

  Song, Qing Kun ^a   Li, Jing ^b   Huang, Rong ^c   Fan, Jin Hu ^b   Zheng, Rong Shou ^b   Zhang, Bao Ning ^b   Zhang, Bin ^d   Tang, Zhong Hua ^e   Xie, Xiao Ming ^f   Yang, Hong Jian ^g   He, Jian Jun ^h   Li, Hui ⁱ   Li, Jia Yuan ^b   Qiao, You Lin ^b   Chen, Wan Qing ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c SICHUAN UNIVERSITY   (China)

^d LIAONING CANCER HOSPITAL AND INSTITUTE   (China)

^e CENTRAL SOUTH UNIVERSITY   (China)

^f SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^g ZHEJIANG CANCER HOSPITAL   (China)

^h XI'AN JIAOTONG UNIVERSITY   (China)

ⁱ SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Breast cancer; China; Onset age; Racial ethnic variation; United States and European Union

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHILD; CHINA; CLINICAL TRIAL; EUROPEAN UNION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; INFANT; MIDDLE AGED; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; TRIPLE NEGATIVE BREAST NEOPLASMS; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; CHILD; CHILD, PRESCHOOL; CHINA; EUROPEAN UNION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; TRIPLE NEGATIVE BREAST NEOPLASMS; UNITED STATES; YOUNG ADULT;

EID: 84921511496     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2014.15.22.10021     Document Type: Article

References (32)

1. American Joint Committee on Cancer (1997). AJCC Cancer staging Manual, Philadelphia, Lippincott-Raven.
2. American joint committee on cancer (2002). AJCC Cancer staging Manual, New York, Springer.
3. Ahmad OB, Boschi-Pinto C, Lopez AD, et al 2001. Age standardization of rates: A New WHO Standard, Geneva, World Health Organization.
4. Bratton MR, Frigo DE, Segar HC, et al (2012). The organochlorine o, p'-DDT Plays a role in coactivator-mediated MAPK crosstalk in MCF-7 breast cancer cells. Environ Health Perspect, 120, 1291-6.
5. Brody JG, Rudel RA (2003). Environmental pollutants and breast cancer. Environ Health Perspect, 111, 1007-19.
6. Caldarella A, Crocetti E, Bianchi S, et al (2011). Female breast cancer status according to ER, PR and HER2 expression: a population based analysis. Pathol Oncol Res, 17, 753-8.
7. de Bruin MA, Kwong A, Goldstein BA, et al (2011). Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations. Fam Cancer, 11, 429-39.
8. Deapen D, Liu L, Perkins C, et al (2002). Rapidly rising breast cancer incidence rates among Asian-American women. Int J Cancer, 99, 747-50.
9. Ferlay J, Shin H, Bray F, et al (2008). GLOBOCAN 2008 v2.0, Cancer incidence and mortality worldwide: IARC CancerBase No. 10 [Internet]. Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr, accessed on 31/08/2012.
10. Hansen J, Lassen CF (2012). Nested case-control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med, 69, 551-6.
11. Hemminki K, Mousavi SM, Sundquist J, et al (2011). Does the breast cancer age at diagnosis differ by ethnicity? A study on immigrants to Sweden. Oncologist, 16, 146-54.
12. Howlader N, Noone A, Krapcho M, et al (2012). SEER cancer statistics review, 1975-2009 (Vintage 2009 Populations), National Cancer Institute. Bethesda, MD. Available from: http://seer.cancer.gov/csr/1975_2009_pops09/.
13. Ingelman-Sundberg M (2004). Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future. Trends Pharmacol Sci, 25, 193-200.
14. Jernstrom H, Chu W, Vesprini D, et al (2001). Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab, 72, 144-54.
15. Kurian AW, Fish K, Shema SJ, et al (2010). Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res, 12, 99.
16. Kwong A, Cheung P, Chan S, et al (2008). Breast cancer in Chinese women younger than age 40: are they different from their older counterparts? World J Surg, 32, 2554-61.
17. Li J, Zhang BN, Fan JH, et al (2011). A nation-wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in China. BMC Cancer, 11, 364.
18. Liu L, Zhang J, Wu AH, et al (2012). Invasive breast cancer incidence trends by detailed race/ethnicity and age. Int J Cancer, 130, 395-404.
19. Manuwald U, Velasco Garrido M, Berger J, et al (2012). Mortality study of chemical workers exposed to dioxins: follow-up 23 years after chemical plant closure. Occup Environ Med, 69, 636-42.
20. Menes TS, Ozao J, Kim U (2007). Breast cancer and ethnicity: strong association between reproductive risk factors and estrogen receptor status in Asian patients-a retrospective study. Breast J, 13, 352-8.
21. Ooi SL, Martinez ME, Li CI (2011). Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat, 127, 729-38.
22. Setiawan VW, Haiman CA, Stanczyk FZ, et al (2006). Racial/ethnic differences in postmenopausal endogenous hormones: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 15, 1849-55.
23. Tavassoli F, Devilee P (2003). Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC, 2003:221-32., Lyon, International Agency for Research on Cancer.
24. Telli ML, Chang ET, Kurian AW, et al (2011). Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat, 127, 471-8.
25. Thompson CL, Li L (2012). Association of sleep duration and breast cancer OncotypeDX recurrence score. Breast Cancer Res Treat, 134, 1291-5.
26. Tilghman SL, Bratton MR, Segar HC, et al (2012). Endocrine disruptor regulation of microRNA expression in breast carcinoma cells. PLoS One, 7, 32754.
27. Villeneuve S, Cyr D, Lynge E, et al (2010). Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case-control study in Europe. Occup Environ Med, 67, 837-44.
28. Wang FL, Chen F, Yin H, et al (2013). Effects of age, breast density and volume on breast cancer diagnosis: a retrospective comparison of sensitivity of mammography and ultrasonography in China's rural areas. Asian Pac J Cancer Prev, 14, 2277-82.
29. Wu LZ, Han RQ, Zhou JY, et al (2014). Incidence and mortality of female breast cancer in Jiangsu, China. Asian Pac J Cancer Prev, 15, 2727-32.
30. Yi M, Liu P, Li X, et al (2012). Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States. Cancer, 118, 4117-25.
31. Zarbo RJ, Hammond ME (2003). Conference summary, Strategic Science symposium. Her-2/neu testing of breast cancer patients in clinical practice. Arch Pathol Lab Med, 127, 549-53.
32. Zheng S, Bai JQ, Li J, et al (2012). The pathologic characteristics of breast cancer in China and its shift during 1999-2008: A national-wide multicenter cross-sectional image over 10 years. Int J Cancer, 131, 2622-31.